Another 4EBP-based therapeutic peptide, Pep8, which mimics the eIF8E bonding domain, can antagonize RBM38, thereby promoting P53 expression, reducing cancer development, and slowing down cancer progression [175]. The gene discussed is TP53; the disease is cancer.